| Protein FDR Confidence: Combined | Accession | Description | Exp. q-value: Combined | Sum PEP Score | Coverage [%] | # Peptides | # PSMs | # Unique Peptides | # AAs | MW [kDa] | calc. pI | Abundance Ratio: (B Stem KO) / (B Stem WT) | Abundance Ratio (log2): (B Stem KO) / (B Stem WT) | Abundance Ratio P-Value: (B Stem KO) / (B Stem WT) | Abundance Ratio Adj. P-Value: (B Stem KO) / (B Stem WT) | Abundance Ratio Variability [%]: (B Stem KO) / (B Stem WT) | Abundances (Grouped): B Stem KO | Abundances (Grouped): B Stem WT | Abundances (Grouped) CV [%]: B Stem KO | Abundances (Grouped) CV [%]: B Stem WT | Abundances (Scaled): F2: 129, Sample, B Stem KO, 1 | Abundances (Scaled): F2: 130, Sample, B Stem KO, 2 | Abundances (Scaled): F2: 131, Sample, B Stem KO, 3 | Abundances (Scaled): F2: 126, Sample, B Stem WT, 1 | Abundances (Scaled): F2: 127, Sample, B Stem WT, 2 | Abundances (Scaled): F2: 128, Sample, B Stem WT, 3 | Abundances (Normalized): F2: 129, Sample, B Stem KO, 1 | Abundances (Normalized): F2: 130, Sample, B Stem KO, 2 | Abundances (Normalized): F2: 131, Sample, B Stem KO, 3 | Abundances (Normalized): F2: 126, Sample, B Stem WT, 1 | Abundances (Normalized): F2: 127, Sample, B Stem WT, 2 | Abundances (Normalized): F2: 128, Sample, B Stem WT, 3 | Abundance: F2: 129, Sample, B Stem KO, 1 | Abundance: F2: 130, Sample, B Stem KO, 2 | Abundance: F2: 131, Sample, B Stem KO, 3 | Abundance: F2: 126, Sample, B Stem WT, 1 | Abundance: F2: 127, Sample, B Stem WT, 2 | Abundance: F2: 128, Sample, B Stem WT, 3 | Abundances Count: F2: 129, Sample, B Stem KO, 1 | Abundances Count: F2: 130, Sample, B Stem KO, 2 | Abundances Count: F2: 131, Sample, B Stem KO, 3 | Abundances Count: F2: 126, Sample, B Stem WT, 1 | Abundances Count: F2: 127, Sample, B Stem WT, 2 | Abundances Count: F2: 128, Sample, B Stem WT, 3 | Biological Process | Cellular Component | Molecular Function | Pfam IDs | Entrez Gene ID | Gene Symbol | Chromosome | Reactome Pathways | Ensembl Gene ID | KEGG Pathways | WikiPathways | # Razor Peptides | Modifications |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| High | P16054 | Protein kinase C epsilon type OS=Mus musculus OX=10090 GN=Prkce PE=1 SV=1 | 0 | 30.28 | 16 | 10 | 11 | 10 | 737 | 83.5 | 7.03 | 1.041 | 0.06 | 0.761787015 | 0.994992347 | 22.95 | 106.4 | 93.6 | 15.62 | 23.67 | 106.3 | 112.5 | 82.8 | 125.4 | 93.6 | 79.5 | 1339.6 | 1418.2 | 1042.9 | 1580.6 | 1179.2 | 1001.4 | 1172.2 | 1349.3 | 1042.9 | 1396.7 | 1101.9 | 966.7 | 8 | 8 | 8 | 8 | 8 | 8 | cell division;cell organization and biogenesis;cellular homeostasis;metabolic process;regulation of biological process;response to stimulus;transport | cytoplasm;cytoskeleton;cytosol;endoplasmic reticulum;Golgi;membrane;mitochondrion;nucleus | catalytic activity;enzyme regulator activity;metal ion binding;nucleotide binding;protein binding | "Pf00069, Pf00130, Pf00168, Pf00433, Pf07714" | 18754 | Prkce | 17 | Role of phospholipids in phagocytosis; Effects of PIP2 hydrolysis; Gastrin-CREB signalling pathway via PKC and MAPK; DAG and IP3 signaling | ENSMUSG00000045038.14 | AGE-RAGE signaling pathway in diabetic complications; Type II diabetes mellitus; MicroRNAs in cancer; Insulin resistance; Sphingolipid signaling pathway; Fc gamma R-mediated phagocytosis; cGMP-PKG signaling pathway; Vascular smooth muscle contraction; Aldosterone synthesis and secretion; Tight junction; Inflammatory mediator regulation of TRP channels | Hypothetical Network for Drug Addiction; G Protein Signaling Pathways; Myometrial Relaxation and Contraction Pathways; Wnt Signaling Pathway; Calcium Regulation in the Cardiac Cell; Wnt Signaling Pathway and Pluripotency | 0 |